EHA Topics-in-Focus Preceptorship on Sickle Cell Disease: From Research to Clinical Management
Dates: January 28–30, 2026
Location: Hôpital Necker-Enfants malades, Paris, France
Chairs: Mariane de Montalembert and Slimane Allali
The travel grant application is now open. For full details, visit our Travel grant application page.
Elevate your expertise and impact patient care by joining the EHA’s second preceptorship on Sickle Cell Disease, designed for early and mid-career hematology specialists, clinicians, lab technicians, and pathologists.
This immersive program, part of the EHA Topics-in-Focus (TIF) initiative, provides a unique opportunity to gain cutting-edge knowledge through lectures, real clinical case-sharing, and practical workshop sessions led by top experts.
Overview
The meeting is part of the EHA Topics-in-Focus (TIF) Hemoglobinopathies Program. The goals of this program are to:
- Educate and expand awareness of increasingly common genetic diseases like sickle cell disease and beta-thalassemia
- Develop and optimize a European regulatory framework for sickle cell disease and beta-thalassemia
The focus of this European regulatory framework will be:
- Education
- Predictive diagnostics
- Innovative treatment and complications management
Program
You can find the full event details on the Preceptorship program page.
Main topics that will be covered are:
- Red cell physiology and physiopathology of SCD
- Laboratory tools to explore red blood cells and diagnosis of hemoglobinopathies
- Management of SCD: Transfusion, Manual exchange transfusion, and erythrocytapheresis
- Complications of SCD
- SCD in adults
- New drugs in SCD
- Curative approaches: HSCT and gene therapy
Learning objectives
After attending this meeting, participants will be able to:
- Gain more knowledge and skills in the diagnosis, management, and treatment of sickle cell disease
- Develop your ability to provide holistic, patient-centered, and culturally sensitive care to patients with sickle cell disease and their families
- Enhance your professional development and career prospects in pediatric hematology and advanced practice medicine
Target audience
The meeting is intended for early- and mid-career specialists who treat and diagnose SCD patients; having 1-2 years’ experience working with SCD patients, along with a medical degree specializing in hematology or a related area, is required.
Meeting category
Clinical
EHA Curriculum sections covered
- Non-malignant disorders: Sickle cell disease.
- Treatment of hematologic disorders: Gene therapy; Allogeneic stem cell transplantation.
- Laboratory diagnosis: Laboratory techniques.
Travel grants
The travel grant application is now open. For full details, visit our travel grant application page.
More on this topic from EHA
- Sickle Cell Disease – EHA Campus Program
- SCD: What Physicians Can Learn From Patients And Carriers – EHA Unplugged podcast series
- Gene therapy in hemoglobinopathies – EHA Campus Course
- Screening for Sickle Cell Disease – EHA Unplugged podcast series
- Gene Therapy Advances in SCD and B-Thalassemia – EHA Unplugged podcast series
- Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia- EHA Unplugged podcast series
If you’re not yet an EHA member, you can find out about the benefits of joining our vibrant global community and accessing the EHA Campus, by visiting our membership page.